The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States
Abstract
We investigated the trends in listing and outcomes of drug‐induced acute liver failure (DIALF) over the last quarter century in the United States using the United Network for Organ Sharing (UNOS) database. We examined waitlisted patients in the UNOS database between 1995 and 2020 with a diagnosis of DIALF and assessed trends in etiologies, demographic and clinical characteristics, and outcomes over 3 periods: 1995‐2003, 2004‐2012, and 2013‐2020. Patients with DIALF and cirrhosis were classified as drug‐induced acute‐on‐chronic liver failure. Implicated agents including acetaminophen (APAP) and herbal or dietary supplements (HDSs) were ascertained. There were 2146 individuals with DIALF during the study period. The observed demographic trends between the earliest and latest period included fewer pediatric patients (18.8% to 13.5%) but with an increasing number of males in non‐APAP DIALF (31.8% to 41.4%) and increased racial diversity in APAP DIALF. Antimicrobials remained the most common non‐APAP agents across all periods, but antiepileptics, propylthiouracil, and mushroom poisoning decreased, while HDSs markedly increased from 2.9% to 24.1% of all non‐APAP DIALF patients. The overall 5‐year post‐liver transplantation (LT) patient survival improved significantly over the 3 periods (69.9% to 77.4% to 83.3%) and was evident for both APAP and non‐APAP DIALF. Over the last quarter century, there has been an 8‐fold increase in HDS‐related liver failure necessitating waitlisting for liver transplantation in the United States. There are other important temporal trends during the study period, including improved survival following LT among both APAP and non‐APAP DIALF patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies have shown that patients with HDS hepatoxicity leading to liver failure are more likely to die or undergo transplantation compared to patients with drug hepatoxicity.133,134”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ekor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
Philips, C. A., Paramaguru, R., Augustine, P., Rajesh, S., Ahamed, R., George, T., & Padsalgi, G. (2019) · Hepatology Communications · doi:10.1002/hep4.1355 · Cited by 32
Research works printed but not linked: 16
- 2004, Liver transplantation for acute liver failure from drug‐induced liver injury in the United States, Liver Transpl, 10, 1018, 10.1002/lt.20204 · DOI · Paper page
- 2009, Outcome of liver transplantation for drug‐induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database, Liver Transpl, 15, 719, 10.1002/lt.21692 · DOI
- 2014, Drug‐induced liver injury and drug development: industry perspective, Semin Liver Dis, 34, 227, 10.1055/s-0034-1375962 · DOI · Paper page
- 2003, Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone, Am J Gastroenterol, 98, 175, 10.1111/j.1572-0241.2003.07175.x · doi:10.1111/j.1572-0241.2003.07175.x
- 2014, DILI and drug development: a regulatory perspective, Semin Liver Dis, 34, 215, 10.1055/s-0034-1375961 · DOI · Paper page
- 2019, Drug‐induced acute‐on‐chronic liver failure in Asian patients, Am J Gastroenterol, 114, 929, 10.14309/ajg.0000000000000201 · DOI · Paper page
- 2016, Drug‐induced liver injury in patients with preexisting chronic liver disease in drug development: how to identify and manage?, Gastroenterology, 151, 1046, 10.1053/j.gastro.2016.10.010 · DOI
- 2015, Features and outcomes of 899 patients with drug‐induced liver injury: the DILIN Prospective Study, Gastroenterology, 148, 1340, 10.1053/j.gastro.2015.03.006 · DOI · Paper page
- 2020, Association of state medicaid expansion with racial/ethnic disparities in liver transplant wait‐listing in the United States, JAMA Netw Open, 3
- 2021, Medicaid expansion association with end‐stage liver disease mortality depends on leniency of medicaid hepatitis C virus coverage, Liver Transpl, 27, 1723, 10.1002/lt.26209 · doi:10.1002/lt.26209
- 2021, Paracetamol‐related intentional drug overdose among young people: a national registry study of characteristics, incidence and trends, 2007‐2018, Soc Psychiatry Psychiatr Epidemiol, 56, 773, 10.1007/s00127-020-01981-y · DOI
- 2019, Paracetamol poisoning‐related hospital admissions and deaths in Australia, 2004‐2017, Med J Aust, 211, 218, 10.5694/mja2.50296 · DOI · Paper page
- 2016, Trends in rates of acetaminophen‐related adverse events in the United States, Pharmacoepidemiol Drug Saf, 25, 590, 10.1002/pds.3906 · DOI
- 2020, Electronic‐prescribing tools improve N‐acetylcysteine prescription accuracy and timeliness for patients who present following a paracetamol overdose: a digital innovation quality‐improvement project, Digit Health, 6
- 2016, Development and pilot of a checklist for management of acute liver failure in the intensive care unit, PLoS One, 11
- 2017, The Incidence of drug‐ and herbal and dietary supplement‐induced liver injury: preliminary findings from gastroenterologist‐based surveillance in the population of the state of delaware, Drug Saf, 40, 783, 10.1007/s40264-017-0547-9 · DOI · Paper page
Cited by
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Han, L., Huang, A., Chen, J., Teng, G., Sun, Y., Chang, B., Liu, H.-L., Xu, M., Lan, X., Liang, Q., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10541-w · Cited by 9
Metadata
- Authors
- Ghabril, M., Ma, J., Patidar, K. R., Nephew, L., Desai, A. P., Orman, E. S., Vuppalanchi, R., Kubal, S., & Chalasani, N.
- Affiliations
- Department of Gastroenterology and Hepatology,Indiana University School of Medicine,Indianapolis,IN
- Department of Transplant Surgery,Indiana University School of Medicine,Indianapolis,IN
- Venue
- Liver Transplantation
- Published
- 2021-11-27
- Volume
- 28
- Issue
- 2
- Pages
- 169-179
- ISSN
- 1527-6465
- 1527-6473
- Cited by
- 29
- References
- 2
- Language
- en
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.